Leading the Charge
in the EP Revolution

Ultra High Resolution Imaging
and Mapping System

View AcQMap System

Latest News

Sep. 17, 2020

Acutus Medical Reports Second Quarter 2020 Financial Results

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020. Reported revenue of $1.1 million in the second quarter of 2020, a 54% increase over the same quarter last year and within the preliminary range disclosed in our IPO prospectus.

Read More
Sep. 17, 2020

Acutus Medical Announces FDA Clearance of Second-Generation AcQMap 3D Imaging & Mapping Catheter

Acutus Medical (Nasdaq: AFIB) today announces FDA 510(k) clearance of the second-generation AcQMap® 3D imaging and mapping catheter which builds on its predecessor, improving handling and deliverability.

Read More
Sep. 8, 2020

Acutus Medical Announces Pulse Field Ablation Program and Initial Pre-Clinical Results

Acutus Medical, Inc. (NASDAQ:AFIB) today announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilizing the AcQMap® System along with tissue-selective, non-thermal pulse field ablation (PFA) via a proprietary Acutus ablation catheter.

Read More